PREMIER HEALTH OF AMERICA IN (PHA.CA) Stock Analyst Earnings Estimates
TSX-V:PHA - TSX Venture Exchange - CA74052G1063 - Common Stock - Currency: CAD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 80.507M 20.83% | 90.39M 12.28% | 158.191M 75.01% | 133.81M -15.41% | 134.15M 0.25% | 141.95M 5.81% | |
| EBITDA YoY % growth | 5.76M -2.41% | 7.778M 35.03% | 6.025M -22.54% | 6.364M 5.63% | 6.901M 8.44% | 7.402M 7.26% | |
| EBIT YoY % growth | 2.337M -32.04% | 3.329M 42.43% | -787K -123.64% | 12.551M 1,694.79% | 14.438M 15.03% | N/A | |
| Operating Margin | 2.90% | 3.68% | -0.50% | 9.38% | 10.76% | N/A | |
| EPS YoY % growth | 0.00 -94.17% | N/A 243.33% | N/A -2,040.00% | -0.12 40.21% | -0.12 -0.86% | -0.12 |
All data in CAD
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | 0.02 141.20% | 0.02 100.00% |
| Revenue Q2Q % growth | 45.84M 10.51% | 46.49M 38.95% |
| EBITDA Q2Q % growth | 4.945M 39.81% | 4.509M -25.12% |
| EBIT Q2Q % growth | 3.517M 318.04% | 3.11M 493.67% |
All data in CAD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 189.57% | 0.02 | % | |
| Q1 2025 Q2Q % growth | 203.00% | 0.01 | % | |
| Q4 2024 Q2Q % growth | 203.00% | 0.01 | % | |
| Q2 2024 Q2Q % growth | -0.02 -2,400.00% | 0.00 | -0.02 | % |
| Q1 2024 Q2Q % growth | -0.01 | 0.00 | -0.01 | % |
| Q4 2023 Q2Q % growth | -0.01 -1,100.00% | 0.01 | -0.02 | -197.09% |
| Q3 2023 Q2Q % growth | -100.00% | 0.00 | % | |
| Q2 2023 Q2Q % growth | 0.00 110.00% | 0.01 | 0.00 | -80.58% |
| Q1 2023 Q2Q % growth | -0.01 -242.86% | 0.00 | -0.01 | % |
| Q4 2022 Q2Q % growth | 0.00 -90.00% | 0.01 | 0.00 | -80.58% |
| Q3 2022 Q2Q % growth | 0.01 -50.00% | -0.01 | 0.02 | 148.54% |
| Q2 2022 Q2Q % growth | -0.01 -150.00% | 0.01 | -0.02 | -294.17% |
| Q1 2022 Q2Q % growth | 0.01 -65.00% | 0.01 | 0.00 | -32.04% |
| Q4 2021 Q2Q % growth | 0.01 | 0.01 | 0.00 | -2.91% |
| Q3 2021 Q2Q % growth | 0.01 | 0.01 | 0.00 | -2.91% |
| Q2 2021 Q2Q % growth | 0.02 | 0.01 | 0.01 | 94.17% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 27.137M -41.36% | 45.201M | -18.064M | -39.96% |
| Q1 2025 Q2Q % growth | 32.132M -13.09% | 44.573M | -12.441M | -27.91% |
| Q4 2024 Q2Q % growth | 33.459M 42.96% | 43.956M | -10.497M | -23.88% |
| Q3 2024 Q2Q % growth | 41.482M 75.67% | 48.307M | -6.825M | -14.13% |
| Q2 2024 Q2Q % growth | 46.277M 112.33% | 44.496M | 1.781M | 4.00% |
| Q1 2024 Q2Q % growth | 36.973M 71.37% | 37.669M | -696K | -1.85% |
| Q4 2023 Q2Q % growth | 23.405M 5.97% | 23.69M | -285K | -1.20% |
| Q3 2023 Q2Q % growth | 23.614M 5.32% | 23.278M | 336K | 1.44% |
| Q2 2023 Q2Q % growth | 21.795M -39.46% | 22.454M | -658.7K | -2.93% |
| Q1 2023 Q2Q % growth | 21.575M 17.16% | 22.866M | -1.291M | -5.65% |
| Q4 2022 Q2Q % growth | 22.087M 25.29% | 23.33M | -1.243M | -5.33% |
| Q3 2022 Q2Q % growth | 22.42M 20.30% | 22.712M | -291.8K | -1.28% |
| Q2 2022 Q2Q % growth | 36M 111.72% | 17.974M | 18.026M | 100.29% |
| Q1 2022 Q2Q % growth | 18.416M 37.84% | 18.334M | 81.7K | 0.45% |
| Q4 2021 Q2Q % growth | 17.629M 154.13% | 16.995M | 633.9K | 3.73% |
| Q3 2021 Q2Q % growth | 18.636M 238.29% | 16.789M | 1.847M | 11.00% |
| Q2 2021 Q2Q % growth | 17.003M 105.01% | 14.317M | 2.686M | 18.76% |
| Q1 2021 Q2Q % growth | 13.36M 297.13% | % | ||
| Q4 2020 Q2Q % growth | 6.937M 109.24% | % | ||
| Q3 2020 Q2Q % growth | 5.509M 117.64% | % | ||
| Q2 2020 Q2Q % growth | 8.294M 43.72% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | 0% | 0% | 0% | 0% |